peptide wiki

Dermorphin

aka DRM

Nootropic / Cognitive banned

Mechanism

Naturally occurring heptapeptide first isolated from the skin of South American Phyllomedusa frogs. It is a highly selective, potent agonist of the mu-opioid receptor (MOR), reported to be roughly 30-40 times more potent than morphine on a molar basis, with low affinity for delta-opioid receptors. Its activity depends on the unusual D-alanine residue at position 2 (one of the few vertebrate peptides containing a D-amino acid) and C-terminal amidation, which confer resistance to peptidases. Dermorphin is not an approved human drug and has no legitimate clinical or nootropic use; it is studied as a pharmacological probe of opioid signaling.

Studied uses

Identification

CAS number77614-16-5
Molecular formulaC40H50N8O10
SequenceTyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH2
Typical doseNo established or legitimate human dose; used only at experimental quantities in laboratory animal studies
Half-lifeNot well characterized in humans; the D-Ala and C-terminal amide confer greater enzymatic stability than typical endogenous opioid peptides

Safety

Not FDA-approved; a potent opioid agonist with the attendant risks of respiratory depression, sedation, dependence, and overdose. Dermorphin gained notoriety as an illicit performance-enhancing 'frog juice' doping agent in horse racing and is a Class 1 prohibited substance in equine competition; in human sport it falls under WADA narcotics. Possession/use outside controlled research is illegal in most jurisdictions.

Vendors selling Dermorphin

VendorSizePriceListed purityTrust
zztai Peptide Ltd 43

Research

Dermorphin blocks apneic response to intravenous bolus injection of fentanyl
Zhuang J, Gao X, Shi S, Xu F. · Toxicology and applied pharmacology (2026) · animal

Background Sudden death induced by intravenous bolus (IVb) injection of overdose fentanyl is the major cause of overdose opioid-induced deaths; however, the relevant countermeasure is lacking.

source →
Nanoassembly-enabled aqueous solid-phase peptide synthesis (ASPPS): a practical DMF-free approach based on the Fmoc strategy
Hojo K, Nonaka A, Manabe Y, Rentier C, Mehrotra A, Hioki K, Kunishima M. · RSC advances (2026) ·

The urgent need for sustainable peptide manufacturing has accelerated efforts to replace conventional N , N -dimethylformamide (DMF)-based solid-phase peptide synthesis (SPPS) with greener alternatives.

source →
Differential opioid receptor expression and biochemical coupling profiles on glia
Kadhim SF, McDonald J, Bird MF, Guerrini R, Calo G, Lambert DG. · Biochemical pharmacology (2026) ·

The opioid receptor family comprises classical; MOP (mu/µ), KOP (kappa/k), DOP(delta/δ) receptors along with non-classical Nociceptin/Orphanin FQ (N/OFQ) peptide receptor (NOP). Expression on glial cells is controversial where there is a role for glia and opioids in pain processing and immunomodulation.

source →
Receptor Binding, Functional Activity, and Cell Viability Assessment of Novel Marine-Based Hybrid Peptides from <i>Raja porosa</i>
Bauer M, Szeleszczuk Ł, Velmurugan BK, Chiang SL, Laskowska AK, Pisklak DM, Szűcs E, Gombos D, Kamysz W, Fehér T, Pielaszkiewicz N, Małek K, Kleczkowska P. · Marine drugs (2026) ·

The hybrid approach remains a compelling strategy for designing molecules that combine enhanced biological activity with a favorable safety profile. Marine peptides, in particular, have attracted significant attention due to their well-documented broad spectrum of biological activities.

source →
The Neurotropic Activity of Novel Dermorphin Analogs Active at Systemic and Noninvasive Administration
Deigin V, Korobov N, Volpina O, Linkova N, Diatlova A, Medvedev D, Krasichkov A, Polyakova V. · International journal of molecular sciences (2025) · animal

The neuropeptide's multifaceted involvement in various components of neural homeostasis impacts pain and behavioral regulation. One of the highly potent neuropeptides is dermorphin, extracted from the skin of the Amazon frog ( Phyllomedusa sauvagei ).

source →
Respiratory and Cardiovascular Activity of LENART01, an Analgesic Dermorphin-Ranatensin Hybrid Peptide, in Anesthetized Rats
Wojciechowski P, Zając D, Górski A, Kamysz W, Kleczkowska P, Kaczyńska K. · International journal of molecular sciences (2025) · animal

Opioids are among the most effective drugs for treating moderate to severe pain. Unfortunately, opioid use, even short-term, can lead to addiction, tolerance, overdose, and respiratory depression.

source →
Dermorphin [D-Arg2, Lys4] (1-4) Amide Attenuates Burn Pain by Inhibiting TRPV1/NR2B Mediated Neuroinflammatory Signalling
Modi A, Uniyal A, Akhilesh, Tiwari V, Chouhan D, Agrawal S, Ummadisetty O, Tiwari V. · Molecular neurobiology (2025) · animal

Burn injury-induced chronic pain is a highly debilitating condition that profoundly impacts the well-being of military veterans and the general population. Current pain management for burn injured patients mainly relies on central opioids, often causing sedation, addiction, and physical dependence.

source →
Bioanalytical methods in doping controls: a review
Thomas A, Walpurgis K, Naumann N, Piper T, Thevis M. · Bioanalysis (2025) · review

The analytical and technological approaches employed in doping analysis are constantly reviewed and updated to allow for keeping pace with progresses in pharmaceutical and medicinal research and the therein inherent options of misuse as performance enhancing drugs or methods.

source →
Metabolic syndrome reduces but does not eliminate the cardioprotective effect of adaptation to hypoxia: the link with changes in the opioid system
Naryzhnaya NV, Derkachev IA, Kurbatov BK, Mukhomedzyanov AV, Kilin M, Kan A, Grab AE, Boschenko AA, Maslov LN. · Pflugers Archiv : European journal of physiology (2025) · animal

Chronic continuous hypoxia (CCH) demonstrates a pronounced protective effect in cardiac ischemia-reperfusion (IR). Opioids and opioid receptors play a significant role in this process. It has been previously shown that metabolic syndrome (MS) impairs the development of adaptive myocardial resistance to IR.

source →
In Vitro and In Vivo Pharmacological Profiles of LENART01, a Dermorphin-Ranatensin Hybrid Peptide
Hochrainer N, Serafin P, D'Ingiullo S, Mollica A, Granica S, Brytan M, Kleczkowska P, Spetea M. · International journal of molecular sciences (2024) ·

Diverse chemical and pharmacological strategies are currently being explored to minimize the unwanted side effects of currently used opioid analgesics while achieving effective pain relief. The use of multitarget ligands with activity at more than one receptor represents a promising therapeutic approach.

source →
Biomimetic Dual-Target Theranostic Nanovaccine Enables Magnetic Resonance Imaging and Chemo/Chemodynamic/Immune Therapy of Glioma
Huang T, Guo Y, Wang Z, Ma J, Shi X, Shen M, Peng S. · ACS applied materials & interfaces (2024) ·

Development of theranostic nanomedicines to tackle glioma remains to be challenging. Here, we present an advanced blood-brain barrier (BBB)-crossing nanovaccine based on cancer cell membrane-camouflaged poly( N -vinylcaprolactam) (PVCL) nanogels (NGs) incorporated with MnO 2 and doxorubicin (DOX).

source →
Dermorphin [D-Arg2, Lys4] (1-4) Amide Alleviates Frostbite-Induced Pain by Regulating TRP Channel-Mediated Microglial Activation and Neuroinflammation
Ummadisetty O, Akhilesh, Gadepalli A, Chouhan D, Patil U, Singh SP, Singh S, Tiwari V. · Molecular neurobiology (2024) · animal

Cold injury or frostbite is a common medical condition that causes serious clinical complications including sensory abnormalities and chronic pain ultimately affecting overall well-being.

source →